|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 PLN | +0.17% |
|
+1.52% | -11.75% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +65.17% | 1 | ||||
| 50.6 | -11.35% | 10 | ||||||
| 20.29 | -4.27% | 7 | ||||||
| - | - | 48.3 | +34.69% | 1 | ||||
| 8.8 | +104.18% | 10 | ||||||
| 27.8 | -4.76% | 5 | ||||||
| 5.7 | -5.63% | 5 | ||||||
| - | 39,500 | +36.44% | 2 | |||||
| 8.333 | +45.18% | 3 | ||||||
| Average | 4,429.78 | +28.85% | 5 | ||||||
| Weighted average by Cap. | 2,221.32 | +15.45% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
